Business
Press Release Nov 29 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 29, 2023, titled "Aurobindo Pharma receives USFDA Approval for Darunavir Tablets, 600 mg and 800 mg.".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 29, 2023, titled \"Aurobindo Pharma receives USFDA Approval for Darunavir Tablets, 600 mg and 800 mg.\". View Attachment","length":358,"tagName":"div"}]